
location_on776, Baxter Street Southeast, Third Ward, Grand Rapids, Kent County, Michigan, 49503, United States
Ardelyx is a commercial-stage biopharmaceutical company dedicated to redefining treatment approaches for patients with significant unmet medical needs. By combining scientific innovation with a collaborative, purpose-driven culture, we strive to create meaningful impact for patients.
Team Ardelyx is united by a shared mission and guided by our core values: Passionate, Fearless, Dedicated, and Inclusive. We foster an inclusive environment where employees are respected, supported, and empowered to make an impact — both within our company and in the lives of patients we serve.
Work model: On-site
776, Baxter Street Southeast, Third Ward, Grand Rapids, Kent County, Michigan, 49503, United States
Grand Rapids, Michigan
Experience in nephrology. Specific knowledge of and relationships with nephrology healthcare professionals, their office/clinic staff, their affiliated dialysis centers, and local patient advocacy groups. Prior sales management experience.
Skills: Pharmaceutical Sales, Biotech Sales, Nephrology, Product Launch, Specialty Pharmacy Distribution, Sales Strategies, Sales Data Analysis, Clinical Data, Disease State Knowledge, Competitive Products.
Education: Bachelor's degree required.
Ardelyx, Inc. is a commercial-stage biopharmaceutical company headquartered in Waltham, Massachusetts, dedicated to the development and commercialization of innovative medicines addressing significant unmet medical needs. Operating within the biotechnology research sector, the organization has successfully launched two commercial products approved in the United States: IBSRELA for irritable bowel syndrome with constipation and XPHOZAH for chronic kidney disease patients on dialysis. The company maintains an active pipeline, including Phase 3 development of tenapanor for chronic idiopathic constipation and RDX10531, a next-generation NHE3 inhibitor with potential applications across multiple therapeutic areas.
Ardelyx has established a global footprint through strategic agreements for the development and commercialization of tenapanor outside the United States. In Japan, Kyowa Kirin commercializes the drug as PHOZEVEL for hyperphosphatemia, while a New Drug Application for the same indication has been approved in China with Fosun Pharma. Additionally, Knight Therapeutics manages the commercialization of IBSRELA in the Canadian market. These partnerships extend the company's reach, ensuring patient access to its therapies in diverse international regions while the organization continues to advance its internal research and development initiatives.
Browse more roles: All Ardelyx, Inc. jobs, sales jobs on Recrutus.
Experience
5+ yrs (Senior)
Education
Bachelor's degree required
Job Type
Full-Time
Recrutus helps candidates discover roles that match their skills and helps teams reach qualified applicants faster. Browse by metro, discipline, or work style — from internships to senior leadership.